Search results

Would the widespread wearing of face masks decrease the spread of coronavirus and COVID-19? Unfortunately, there is no clear-cut right or wrong answer to the raging face mask debate. If there is any benefit, it probably lies in protecting the public from a potentially infected wearer rather than the wearer from a potentially infected public.

Just when you thought the pandemic of misinformation could not get worse, Rudy Giuliani, President Trump's personal attorney, surfaces to add his misinformative spin. His website has two video presentations on suspect therapies for COVID-19. Let's consider them in turn.

As we get used to sheltering in place, speculation turns to an exit strategy. Especially impatient are those most concerned with the economy. If you follow COVID-19 coverage, there are any number of possible approaches going forward.

On Rachel Maddow's MSNBC show, New York Times science and health reporter Donald McNeil praised China's mass quarantine camps as the best way to fight the COVID-19 pandemic. A CBC documentary reveals what that policy entails: Citizens are literally being dragged out of their homes as they cry and scream. Others have their doors welded shut.

Throughout this pandemic, we have heard many heartbreaking and heartwarming stories of how we're responding and coping. Many of those have been about the elderly, accounts written by adult children describing how they miss contact with their parents, segregated from them by institutional living. But here is a first-hand account by an older couple in their mid-80s, who describe what they are thinking and living through during this staggering health crisis.

Last week Arizona Governor Doug Ducey exercised his best judgment, aiming to expand the scope of the health care workforce during the COVID-19 public health emergency. And yet health care practitioners lack the same ability, based upon their knowledge and their patients’ circumstances, to use their best judgment when treating pain.

When coronavirus patients are admitted to all general hospitals, the risk of infecting other patients as well as hospital personnel is a serious concern. One way to address this problem is to consider isolating coronavirus patients to certain designated medical centers thus reducing the likelihood of exposure to other patients and their attending medical staff.

The Center for Medicare and Medicaid Services recently issued a national emergency order to pay doctors for services rendered to patients in states in which they are not licensed to practice, so long as they hold an equivalent license in another state. This would be a good move. Luckily, many states are already ahead of the federal government on implementing such measures.

The seasonality of coronavirus infections is the basis of hope. If COVID-19 goes on until July – as it well may – it will be disastrous for world health and for the global economy. But, if it is like SARS, it may then die out and not come back. Is this wishful thinking?  Yes, but based on scientific fact. Should we hope for the best but prepare for the worst? Absolutely. 

In short, the public is often worried about chemical exposure, as they should be when such exposure exceeds a safe dose. The public’s interest is best served by trusting experts dedicated to public health protection and not by withholding scientific data from independent analysis.

Two of the experimental coronavirus drugs, chloroquine, and hydroxychloroquine are a breeze to synthesize. But remdesivir, possibly the most promising candidate, is anything but. It's a royal pain. Here's why.

In the Digital Age, we have access to more information than at any time in human history. But that doesn't stop the spread of conspiracy theories. Here are the best (worst?) ones involving the new coronavirus and the disease COVID-19.

If there was any effect of this drug on COVID-19, it was minimal. Hydroxychloroquine, whose toxicity is far lower, may be safer than chloroquine. But that doesn't matter if the drugs are ineffective.

As the number of patients requiring ventilatory assistance to survive COVID-19 rises, and with no new ventilators in sight, a "Hail Mary" technique is starting to be used. Can a machine designed to help one patient be reconfigured to support two or more? And can it protect society at large, even just a bit, from surging hospital admissions?

On tap this time: Why coronavirus containment failed, learning from history, and how COVID-19 hijacks your body. Also, a ritual in troubled times ... giving moss the attention it deserves ... and finally, the reason to slack off. (There had to be a good reason, right?)

Peter Fairley, an environmental journalist and contributing editor for MIT Technology Review, cited an anti-vaccine website, DeSmogBlog, in a smear directed at our organization. Simultaneously, he spread misinformation about influenza and COVID-19 and endorses advice that contradicts that of the CDC and World Health Organization.

For those of you staying at home who might be considering performing CPR, a tracheostomy, or intubating someone in the neighborhood [1], an N95 mask is a necessity; otherwise, you are diverting "war-time" supplies from the first responder and health care army.

DeSmogBlog, a climate activist website that ruthlessly smears scientists, is headed by Brendan DeMelle, an anti-vaxxer who helped RFK, Jr. write an infamous and since-retracted article linking vaccines to autism.

"You never let a serious crisis go to waste. And what I mean by that it's an opportunity to do things you think you could not do before." -- Rahm Emmanuel [1]

The website’s strategy is clear: Throw ad hominem attacks as early and as often as possible. Why? Because it works. And the people most eager to spread the lies are self-proclaimed skeptical scientists and journalists.

Chloroquine, the old malaria drug, is making news as a potential therapy for coronavirus. Does it belong in the headlines for its antiviral properties, or is it just hype and bluster? Will it become a drug? Let's find out.

One way in which COVID-19 is not novel is that the disease follows a set pattern: first onset, then the body’s response, followed (hopefully) by recovery. To get a better sense of how this pandemic might play out, we should consider what we know about COVID-19’s timeline. 

At the current time, influenza remains the far bigger threat to global public health than COVID-19. Though COVID-19 has a higher case-fatality rate, influenza infects far more people. Of course, that could change.

As the horror known as the coronavirus tightens its grip on the world, and a vaccine is years away, our best hope is an antiviral drug that minimizes the damage caused by coronavirus replication. New data on favipiravir, a repurposed drug originally discovered in Japan, looks promising in trials in China. But nothing is ever straightforward in drug discovery -- and that is no different here. Here's a summary of the new findings.

Here's what's on tap: The how-to of COVID-19 testing ... an extremely well-informed skeptic wonders about our pandemic actions ... a possible silver lining to the massive economic fallout ... and what's behind the long lines of climbers trying to summit Mount Everest?